United Pharmaceutical: The company's raw material drug product Levonorgestrel has passed the pre-qualification of the World Health Organization.

Lianhuan Pharmaceutical announced that the company has received notification from the World Health Organization that its raw material drug product Levonorgestrel has passed the WHO pre-qualification. The product had previously passed the on-site inspection for WHO pre-qualification and the drug master file review, and now it has fully passed the WHO pre-qualification. This pre-qualification will not have a significant impact on the company's current business performance, but there is uncertainty in future product sales orders.